These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18585453)

  • 1. Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress.
    Liu Y; Mackness B; Mackness M
    Free Radic Biol Med; 2008 Sep; 45(6):743-8. PubMed ID: 18585453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage paraoxonase 1 (PON1) binding sites.
    Efrat M; Aviram M
    Biochem Biophys Res Commun; 2008 Nov; 376(1):105-10. PubMed ID: 18762170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development.
    Aviram M; Rosenblat M
    Free Radic Biol Med; 2004 Nov; 37(9):1304-16. PubMed ID: 15454271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
    Rozenberg O; Rosenblat M; Coleman R; Shih DM; Aviram M
    Free Radic Biol Med; 2003 Mar; 34(6):774-84. PubMed ID: 12633754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies.
    Rosenblat M; Volkova N; Aviram M
    Biofactors; 2014; 40(5):536-45. PubMed ID: 25230879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M; Karry R; Aviram M
    Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
    Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
    Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
    J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action.
    Nguyen SD; Sok DE
    Free Radic Res; 2003 Dec; 37(12):1319-30. PubMed ID: 14753756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paraoxonase gene family and atherosclerosis.
    Ng CJ; Shih DM; Hama SY; Villa N; Navab M; Reddy ST
    Free Radic Biol Med; 2005 Jan; 38(2):153-63. PubMed ID: 15607899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2.
    Shamir R; Hartman C; Karry R; Pavlotzky E; Eliakim R; Lachter J; Suissa A; Aviram M
    Free Radic Biol Med; 2005 Aug; 39(3):336-44. PubMed ID: 15993332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects.
    Tavori H; Aviram M; Khatib S; Musa R; Nitecki S; Hoffman A; Vaya J
    Free Radic Biol Med; 2009 Mar; 46(5):607-15. PubMed ID: 19103284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux.
    Rosenblat M; Gaidukov L; Khersonsky O; Vaya J; Oren R; Tawfik DS; Aviram M
    J Biol Chem; 2006 Mar; 281(11):7657-65. PubMed ID: 16407304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity.
    Rosenblat M; Volkova N; Aviram M
    Biofactors; 2011; 37(6):462-7. PubMed ID: 22162319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-induced copper ion-mediated low density lipoprotein oxidation increases during in vivo monocyte-to-macrophage differentiation.
    Fuhrman B; Shiner M; Volkova N; Aviram M
    Free Radic Biol Med; 2004 Jul; 37(2):259-71. PubMed ID: 15203197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques.
    Marsillach J; Camps J; Beltran-Debón R; Rull A; Aragones G; Maestre-Martínez C; Sabench F; Hernández M; Castillo DD; Joven J; Mackness M; Mackness B
    Eur J Clin Invest; 2011 Mar; 41(3):308-14. PubMed ID: 20964682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism.
    Fuhrman B; Khateeb J; Shiner M; Nitzan O; Karry R; Volkova N; Aviram M
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1361-7. PubMed ID: 18436804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.